Prognostic Model for Survival and Recurrence in Patients with Early-Stage Cervical Cancer: A Korean Gynecologic Oncology Group Study (KGOG 1028)
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Purpose We aimed to develop and validate individual prognostic models in a large cohort of cervical cancer patients that were primarily treated with radical hysterectomy. Materials and Methods We analyzed 1,441 patients with early-stage cervical cancer treated between 2000 and 2008 from the Korean Gynecologic Oncology Group multi-institutional cohort: a train cohort (n=788) and a test cohort (n=653). Models predicting the risk for overall survival (OS), disease- free survival (DFS), lymphatic recurrence and hematogenous recurrence were developed using Cox analysis and stepwise backward selection and best-model options. The prognostic performance of each model was assessed in an independent patient cohort. Model-classified risk groups were compared to groups based on traditional risk factors. Results Independent risk factors for OS, DFS, lymphatic recurrence, and hematogenous recurrence were identified for prediction model development. Different combinations of risk factors were shown for each outcome with best predictive value. In train cohort, area under the curve (AUC) at 2 and 5 years were 0.842/0.836 for recurrence, and 0.939/0.882 for OS. When applied to a test cohort, the model also showed accurate prediction result (AUC at 2 and 5 years were 0.799/0.723 for recurrence, and 0.844/0.806 for OS, respectively). The Kaplan-Meier plot by proposed model-classified risk groups showed more distinctive survival differences between each risk group. Conclusion We developed prognostic models for OS, DFS, lymphatic and hematogenous recurrence in patients with early-stage cervical cancer. Combining weighted clinicopathologic factors, the proposed model can give more individualized predictions in clinical practice.
Abstract
Purpose We aimed to develop and validate individual prognostic models in a large cohort of cervical cancer patients that were primarily treated with radical hysterectomy. Materials and Methods We analyzed 1,441 patients with early-stage cervical cancer treated between 2000 and 2008 from the Korean Gynecologic Oncology Group multi-institutional cohort: a train cohort (n=788) and a test cohort (n=653). Models predicting the risk for overall survival (OS), disease- free survival (DFS), lymphatic recurrence and hematogenous recurrence were developed using Cox analysis and stepwise backward selection and best-model options. The prognostic performance of each model was assessed in an independent patient cohort. Model-classified risk groups were compared to groups based on traditional risk factors. Results Independent risk factors for OS, DFS, lymphatic recurrence, and hematogenous recurrence were identified for prediction model development. Different combinations of risk factors were shown for each outcome with best predictive value. In train cohort, area under the curve (AUC) at 2 and 5 years were 0.842/0.836 for recurrence, and 0.939/0.882 for OS. When applied to a test cohort, the model also showed accurate prediction result (AUC at 2 and 5 years were 0.799/0.723 for recurrence, and 0.844/0.806 for OS, respectively). The Kaplan-Meier plot by proposed model-classified risk groups showed more distinctive survival differences between each risk group. Conclusion We developed prognostic models for OS, DFS, lymphatic and hematogenous recurrence in patients with early-stage cervical cancer. Combining weighted clinicopathologic factors, the proposed model can give more individualized predictions in clinical practice.
참고문헌 (30)
- Ferlay J, "Cancer incidence and mortality worldwide : sources, methods and major patterns in GLOBOCAN 2012", Int J Cancer, 136, pp.E359~E386 (2015)
- 이원철, "Establishment of a Korea HPV cohort study", Journal of Gynecologic Oncology, 24(1), pp.59~65 (2013), 대한부인종양학회
- Delgado G, "Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix : a Gynecologic Oncology Group study", Gynecol Oncol, 38, pp.352~357 (1990)
- Landoni F, "Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer", Lancet, 350, pp.535~540 (1997)
- Sedlis A, "A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy : a Gynecologic Oncology Group study", Gynecol Oncol, 73, pp.177~183 (1999)
- Peters WA 3rd, "Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix", J Clin Oncol, 18, pp.1606~1613 (2000)
- Barter JF, "Complications of combined radical hysterectomy-postoperative radiation therapy in women with early stage cervical cancer", Gynecol Oncol, 32, pp.292~296 (1989)
- Lagasse LD, "Results and complications of operative staging in cervical cancer : experience of the Gynecologic Oncology Group", Gynecol Oncol, 9, pp.90~98 (1980)
- Sevin BU, "Prognostic factors of early stage cervical cancer treated by radical hysterectomy", Cancer, 76(10 Suppl), pp.1978~1986 (1995)
- Soisson AP, "Adjuvant radiotherapy following radical hysterectomy for patients with stage IB and IIA cervical cancer", Gynecol Oncol, 37, pp.390~395 (1990)
- Kristensen GB, "Tumor size, depth of invasion, and grading of the invasive tumor front are the main prognostic factors in early squamous cell cervical carcinoma", Gynecol Oncol, 74, pp.245~251 (1999)
- Zaino RJ, "Histopathologic predictors of the behavior of surgically treated stage IB squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study", Cancer, 69, pp.1750~1758 (1992)
- Tsai CS, "The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy", Gynecol Oncol, 75, pp.328~333 (1999)
- Ryu SY, "Intermediate-risk grouping of cervical cancer patients treated with radical hysterectomy : a Korean Gynecologic Oncology Group study", Br J Cancer, 110, pp.278~285 (2014)
- Abu-Rustum NR, "A nomogram for predicting overall survival of women with endometrial cancer following primary therapy : toward improving individualized cancer care", Gynecol Oncol, 116, pp.399~403 (2010)
- Ho CM, "Multivariate analysis of the prognostic factors and outcomes in early cervical cancer patients undergoing radical hysterectomy", Gynecol Oncol, 93, pp.458~464 (2004)
- Lai CH, "Role of human papillomavirus genotype in prognosis of early-stage cervical cancer undergoing primary surgery", J Clin Oncol, 25, pp.3628~3634 (2007)
- Yuan CC, "Prognosis-predicting system based on factors related to survival of cervical carcinoma", Int J Gynaecol Obstet, 63, pp.163~167 (1998)
- Greenland S, "Problems due to small samples and sparse data in conditional logistic regression analysis", Am J Epidemiol, 151, pp.531~539 (2000)
- Heagerty PJ, "Time-dependent ROC curves for censored survival data and a diagnostic marker", Biometrics, 56, pp.337~344 (2000)
- Sevin BU, "Surgically defined prognostic parameters in patients with early cervical carcinoma : a multivariate survival tree analysis", Cancer, 78, pp.1438~1446 (1996)
- Smiley LM, "Prognostic factors in stage IB squamous cervical cancer patients with low risk for recurrence", Obstet Gynecol, 77, pp.271~275 (1991)
- Ishikawa H, "Prognostic factors of adenocarcinoma of the uterine cervix", Gynecol Oncol, 73, pp.42~46 (1999)
- Odell EW, "The prognostic value of individual histologic grading parameters in small lingual squamous cell carcinomas. The importance of the pattern of invasion", Cancer, 74, pp.789~794 (1994)
- Biewenga P, "Validation of existing prognostic models in patients with early-stage cervical cancer", Gynecol Oncol, 115, pp.277~284 (2009)
- Van de Putte G, "Risk grouping in stage IB squamous cell cervical carcinoma", Gynecol Oncol, 99, pp.106~112 (2005)
- Aoki Y, "High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation", Gynecol Oncol, 77, pp.305~309 (2000)
- Lai CH, "Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of Stage IB or II cervical carcinoma patients with or without pelvic lymph node metastases : an analysis of 891 cases", Cancer, 85, pp.1537~1546 (1999)
- Ramirez PT, "Minimally invasive versus abdominal radical hysterectomy for cervical cancer", N Engl J Med, 379, pp.1895~1904 (2018)
- Benard VB, "Cervical cancer survival in the United States by race and stage(2001-2009) : findings from the CONCORD-2 study", Cancer, 123, pp.5119~5137 (2017)